cancer clinical trials in springfield, MA
|
Baystate Medical Center
Springfield, Massachusetts 01199 Colorectal Cancer
|
|
Baystate Medical Center
Springfield, Massachusetts 01199 Lymphoma
|
|
Baystate Regional Cancer Program at D'Amour Center for Cancer Care
Springfield, Massachusetts 01199 Lymphoma
|
|
Baystate Medical Center
Springfield, Massachusetts 01199 Fever, Sweats, and Hot Flashes, Neutropenia, Unspecified Childhood Solid Tumor, Protocol Specific
|
|
Baystate Regional Cancer Program at D'Amour Center for Cancer Care
Springfield, Massachusetts 01199 Breast Cancer
|
|
Baystate Regional Cancer Program at Baystate Medical Center
Springfield, Massachusetts 01107 Sarcoma
|
|
Baystate Regional Cancer Program at D'Amour Center for Cancer Care
Springfield, Massachusetts 01199 Breast Cancer
|
|
Baystate Medical Center
Springfield, Massachusetts 01199 Leukemia
|
|
Baystate Medical Center
Springfield, Massachusetts 01199 Brain and Central Nervous System Tumors
|
|
Baystate Medical Center
Springfield, Massachusetts 01199 Leukemia
|
|
Baystate Regional Cancer Program at D'Amour Center for Cancer Care
Springfield, Massachusetts 01199 Lung Cancer
|
|
Baystate Regional Cancer Program
Springfield, Massachusetts 01107 Breast Cancer
|
|
Baystate Medical Center
Springfield, Massachusetts 01199 Childhood Embryonal Tumor, Childhood Extracranial Germ Cell Tumor, Childhood Extragonadal Germ Cell Tumor, Childhood Malignant Ovarian Germ Cell Tumor, Childhood Malignant Testicular Germ Cell Tumor, Childhood Teratoma, Ovarian Embryonal Carcinoma, Ovarian Yolk Sac Tumor, Stage II Malignant Testicular Germ Cell Tumor, Stage IIA Ovarian Germ Cell Tumor, Stage IIB Ovarian Germ Cell Tumor, Stage IIC Ovarian Germ Cell Tumor, Stage III Malignant Testicular Germ Cell Tumor, Stage IIIA Ovarian Germ Cell Tumor, Stage IIIB Ovarian Germ Cell Tumor, Stage IIIC Ovarian Germ Cell Tumor, Testicular Choriocarcinoma and Yolk Sac Tumor, Testicular Embryonal Carcinoma
|
|
Baystate Regional Cancer Program at D'Amour Center for Cancer Care
Springfield, Massachusetts 01199 Breast Cancer
|
|
Baystate Regional Cancer Program at D'Amour Center for Cancer Care
Springfield, Massachusetts 01199 Lung Cancer
|
|
Baystate Regional Cancer Program at D'Amour Center for Cancer Care
Springfield, Massachusetts 01199 Endometrial Cancer
|
|
Baystate Regional Cancer Program at D'Amour Center for Cancer Care
Springfield, Massachusetts 01199 Leukemia
|
|
Baystate Medical Center
Springfield, Massachusetts 01199 Adenocarcinoma of the Colon, Stage III Colon Cancer
|
|
Baystate Regional Cancer Program at Baystate Medical Center
Springfield, Massachusetts 01107 Kidney Cancer
|
|
Baystate Regional Cancer Program at D'Amour Center for Cancer Care
Springfield, Massachusetts 01199 Leukemia
|
|
Baystate Medical Center
Springfield, Massachusetts 01199 Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer
|
|
Baystate Regional Cancer Program at D'Amour Center for Cancer Care
Springfield, Massachusetts 01199 Metastatic Cancer, Prostate Cancer
|
|
Baystate Medical Center
Springfield, Massachusetts 01199 Non-Small Cell Lung Cancer
|
|
Baystate Medical Center
Springfield, Massachusetts 01199 Brenner Tumor, Fallopian Tube Cancer, Ovarian Clear Cell Cystadenocarcinoma, Ovarian Endometrioid Adenocarcinoma, Ovarian Mixed Epithelial Carcinoma, Ovarian Mucinous Cystadenocarcinoma, Ovarian Serous Cystadenocarcinoma, Ovarian Undifferentiated Adenocarcinoma, Primary Peritoneal Cavity Cancer, Stage III Ovarian Epithelial Cancer, Stage IV Ovarian Epithelial Cancer
|
|
GSK Investigational Site
Springfield, Massachusetts 01107 Neoplasms, Breast
|
|
Baystate Regional Cancer Program at D'Amour Center for Cancer Care
Springfield, Massachusetts 01199 Colorectal Cancer
|
|
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Springfield, Massachusetts Glioblastoma
|
|
Baystate Medical Center
Springfield, Massachusetts 01199 Estrogen Receptor-positive Breast Cancer, HER2-negative Breast Cancer, Progesterone Receptor-positive Breast Cancer, Stage IA Breast Cancer, Stage IB Breast Cancer, Stage II Breast Cancer, Stage IIIB Breast Cancer
|
|
Baystate Medical Center
Springfield, Massachusetts 01199 Stage IB Non-small Cell Lung Cancer, Stage IIA Non-small Cell Lung Cancer, Stage IIB Non-small Cell Lung Cancer, Stage IIIA Non-small Cell Lung Cancer
|
|
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Springfield, Massachusetts Non Hodgkin Lymphoma
|
|
Baystate Regional Cancer Program at D'Amour Center for Cancer Care
Springfield, Massachusetts 01199 Leukemia
|
|
GSK Investigational Site
Springfield, Massachusetts 01107 Neoplasms, Breast
|
|
Baystate Regional Cancer Program at D'Amour Center for Cancer Care
Springfield, Massachusetts 01199 Esophageal Cancer
|
|
Baystate Regional Cancer Program at D'Amour Center for Cancer Care
Springfield, Massachusetts 01199 Breast Cancer
|
|
Baystate Medical Center
Springfield, Massachusetts 01199 Male Breast Cancer, Stage IA Breast Cancer, Stage IB Breast Cancer, Stage II Breast Cancer, Stage IIIA Breast Cancer, Stage IIIB Breast Cancer
|
|
GSK Investigational Site
Springfield, Massachusetts 01107 Neoplasms, Prostate, Prostate Cancer
|
|
GSK Investigational Site
Springfield, Massachusetts 01107 Lung Cancer, Non-Small Cell
|
|
GSK Investigational Site
Springfield, Massachusetts 01107 Neoplasms, Breast, Breast Cancer
|
|
Baystate Medical Center
Springfield, Massachusetts 01199 Endometrial Cancer
|
|
Baystate Medical Center
Springfield, Massachusetts 01199 Breast Cancer
|
|
Baystate Regional Cancer Program at D'Amour Center for Cancer Care
Springfield, Massachusetts 01199 Lung Cancer, Radiation Toxicity
|
|
Baystate Medical Center
Springfield, Massachusetts 01199 Pancreatic Pseudocyst
|
|
Baystate Medical Center
Springfield, Massachusetts 01199 Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma, Recurrent Metastatic Squamous Neck Cancer With Occult Primary, Recurrent Salivary Gland Cancer, Recurrent Squamous Cell Carcinoma of the Hypopharynx, Recurrent Squamous Cell Carcinoma of the Larynx, Recurrent Squamous Cell Carcinoma of the Lip and Oral Cavity, Recurrent Squamous Cell Carcinoma of the Nasopharynx, Recurrent Squamous Cell Carcinoma of the Oropharynx, Recurrent Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity, Recurrent Verrucous Carcinoma of the Larynx, Recurrent Verrucous Carcinoma of the Oral Cavity, Salivary Gland Squamous Cell Carcinoma, Stage IV Salivary Gland Cancer, Stage IV Squamous Cell Carcinoma of the Hypopharynx, Stage IV Squamous Cell Carcinoma of the Larynx, Stage IV Squamous Cell Carcinoma of the Lip and Oral Cavity, Stage IV Squamous Cell Carcinoma of the Nasopharynx, Stage IV Squamous Cell Carcinoma of the Oropharynx, Stage IV Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity, Stage IV Verrucous Carcinoma of the Larynx, Stage IV Verrucous Carcinoma of the Oral Cavity, Tongue Cancer, Untreated Metastatic Squamous Neck Cancer With Occult Primary
|
|
Baystate Medical Center
Springfield, Massachusetts 01199 Stage I Multiple Myeloma, Stage II Multiple Myeloma, Stage III Multiple Myeloma
|
|
Baystate Regional Cancer Program at D'Amour Center for Cancer Care
Springfield, Massachusetts 01199 Leukemia
|
|
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Springfield, Massachusetts Non Small Cell Lung Cancer
|
|
GSK Investigational Site
Springfield, Massachusetts 01107 Carcinoma, Renal Cell
|
|
GSK Investigational Site
Springfield, Massachusetts 01107 WT1-positive Acute Myeloid Leukemia, Leukaemia, Myelocytic, Acute
|
|
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Springfield, Massachusetts Non-small Cell Lung Cancer
|
|
GSK Investigational Site
Springfield, Massachusetts 01107 Melanoma
|
|
Baystate Medical Center
Springfield, Massachusetts 01199 Cervical Adenocarcinoma, Cervical Adenosquamous Cell Carcinoma, Cervical Squamous Cell Carcinoma, Recurrent Cervical Cancer, Stage IVB Cervical Cancer
|
|
1199.14.1182 Boehringer Ingelheim Investigational Site
Springfield, Massachusetts Carcinoma, Non-Small-Cell Lung
|
|
Baystate Regional Cancer Program at D'Amour Center for Cancer Care
Springfield, Massachusetts 01199 Leukemia
|
|
Community Research Initiative of New England
Springfield, Massachusetts HIV Infection
|
|
Baystate Regional Cancer Program at D'Amour Center for Cancer Care
Springfield, Massachusetts 01199 Breast Cancer, Metastatic Cancer, Multiple Myeloma and Plasma Cell Neoplasm, Musculoskeletal Complications, Pain, Prostate Cancer, Urinary Complications
|
|
Baystate Medical Center
Springfield, Massachusetts 01199 Sepsis, Acute Lung Injury, Acute Respiratory Distress Syndrome
|
|
D'Amour Center for Cancer Care
Springfield, Massachusetts 01107 Adult Giant Cell Glioblastoma, Adult Glioblastoma, Adult Gliosarcoma
|
|
Baystate Medical Center
Springfield, Massachusetts 01199 Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer
|
|
Baystate Medical Center
Springfield, Massachusetts 01199 Atypical Endocervical Glandular Cell of Undetermined Significance, Atypical Endometrial Hyperplasia, Atypical Glandular Cell of Undetermined Significance, Cervical Cancer, Cervical Intraepithelial Neoplasia Grade 2, Cervical Intraepithelial Neoplasia Grade 3, Human Papilloma Virus Infection
|
|
Baystate Regional Cancer Program at D'Amour Center for Cancer Care
Springfield, Massachusetts 01199 Cancer
|
|
Baystate Regional Cancer Program at D'Amour Center for Cancer Care
Springfield, Massachusetts 01199 Leukemia, Lymphoma
|
|
Baystate Regional Cancer Program at D'Amour Center for Cancer Care
Springfield, Massachusetts 01199 Leukemia, Neoplasm of Uncertain Malignant Potential, Unspecified Childhood Solid Tumor, Protocol Specific
|
|
Baystate Regional Cancer Program at D'Amour Center for Cancer Care
Springfield, Massachusetts 01199 Kidney Cancer, Nonneoplastic Condition
|
|
Baystate Regional Cancer Program at D'Amour Center for Cancer Care
Springfield, Massachusetts 01199 Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer
|
|
Baystate Regional Cancer Program at D'Amour Center for Cancer Care
Springfield, Massachusetts 01199 Sarcoma
|
|
Baystate Regional Cancer Program at D'Amour Center for Cancer Care
Springfield, Massachusetts 01199 Lymphoma
|
|
Baystate Regional Cancer Program at D'Amour Center for Cancer Care
Springfield, Massachusetts 01199 Neuroblastoma
|
|
GSK Investigational Site
Springfield, Massachusetts 01107 Cancer
|
|
Baystate Medical Center
Springfield, Massachusetts 01199 Metastatic Breast Cancer
|
|
Baystate Regional Cancer Program at D'Amour Center for Cancer Care
Springfield, Massachusetts 01199 Prostate Cancer
|
|
Baystate Medical Center
Springfield, Massachusetts 01199 Distal Urethral Cancer, Metastatic Transitional Cell Cancer of the Renal Pelvis and Ureter, Proximal Urethral Cancer, Recurrent Bladder Cancer, Recurrent Prostate Cancer, Recurrent Transitional Cell Cancer of the Renal Pelvis and Ureter, Recurrent Urethral Cancer, Stage IV Bladder Cancer, Stage IV Prostate Cancer, Transitional Cell Carcinoma of the Bladder, Urethral Cancer Associated With Invasive Bladder Cancer
|
|
Baystate Regional Cancer Program at D'Amour Center for Cancer Care
Springfield, Massachusetts 01199 Endometrial Cancer
|
|
Baystate Medical Center
Springfield, Massachusetts 01199 Brenner Tumor, Ovarian Clear Cell Cystadenocarcinoma, Ovarian Endometrioid Adenocarcinoma, Ovarian Mixed Epithelial Carcinoma, Ovarian Mucinous Cystadenocarcinoma, Ovarian Serous Cystadenocarcinoma, Ovarian Undifferentiated Adenocarcinoma, Stage IIA Fallopian Tube Cancer, Stage IIA Ovarian Epithelial Cancer, Stage IIA Primary Peritoneal Cavity Cancer, Stage IIB Fallopian Tube Cancer, Stage IIB Ovarian Epithelial Cancer, Stage IIB Primary Peritoneal Cavity Cancer, Stage IIC Fallopian Tube Cancer, Stage IIC Ovarian Epithelial Cancer, Stage IIC Primary Peritoneal Cavity Cancer, Stage IIIA Fallopian Tube Cancer, Stage IIIA Ovarian Epithelial Cancer, Stage IIIA Primary Peritoneal Cavity Cancer, Stage IIIB Fallopian Tube Cancer, Stage IIIB Ovarian Epithelial Cancer, Stage IIIB Primary Peritoneal Cavity Cancer, Stage IIIC Fallopian Tube Cancer, Stage IIIC Ovarian Epithelial Cancer, Stage IIIC Primary Peritoneal Cavity Cancer, Stage IV Fallopian Tube Cancer, Stage IV Ovarian Epithelial Cancer, Stage IV Primary Peritoneal Cavity Cancer
|
|
Baystate Regional Cancer Program at D'Amour Center for Cancer Care
Springfield, Massachusetts 01199 Ovarian Cancer, Sarcoma
|
|
GSK Investigational Site
Springfield, Massachusetts 01107 Cancer
|
